Following the results of the expert voting at the XXII^nd All-Russian Pharmaceutical Contest “Platinum Ounce”, Aquadetrim by JSC “Akrikhin” was awarded the prestigious “OTC Drug Product of the Year” award for the second year in a row.

Once again, Aquadetrim won the title of the Drug Product of the Year in the OTC sub-nomination. As of now, Aquadetrim is the leading vitamin D product on the Russian market and is the absolute leader in terms of consumption . The brand offers the widest selection of vitamin D products in various dosage forms and doses, allowing for convenient daily usage by the patients of all age groups.

Aquadetrim and other winners of the XXIInd All-Russian Pharmaceutical Contest “Platinum Ounce”, were announced on 14 April 2022 at the award ceremony.

Denis Chetverikov, President of JSC “Akrikhin”, commented on the victory in the contest:

Platinum Ounce is one of the most respectable pharmaceutical awards in our country. Receiving this award means major recognition for any industry participant. I’d like to thank the expert community for their trust in JSC “Akrikhin” and Aquadetrim brand. While taking into account the expectations and demands of the consumers, we always set new goals for ourselves, which allows the company to develop and provide the whole country with modern, affordable, and high-quality pharmaceuticals.

¹According to the Retail Audit of Registered Drugs in Russia database maintained by IQVIA Solutions, as of January to December 2021, the Aquadetrim brand is the leader in terms of sales of drug products containing vitamin D (INN: colecalciferol) in both packages and roubles in wholesale and retail prices.
²Millward Brown, Brand Tracking, 2021; 2. 8 out of 10 men who consume vitamin D take Aquadetrim (80 % of men), 7 out of 10 women who consume vitamin D take Aquadetrim (67 % of women), according to GFK Consumer Panel Study, 2021.